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Glial cell line-derived neurotrophic factor (GDNF) signaling through its receptor GFRα1 
plays an important role in many biological processes including cell survival, proliferation 
and differentiation.  The aim of this project was to isolate and characterize both Gdnf and 
Gfrα1 from the medaka fish (Oryzias latipes).  A full length cDNA for the medaka gfrα1 
was obtained by RT-PCR followed by RACE.  It is 2551 bp long and has an open reading 
frame of 1401 bp for 466 amino acids.  The predicted protein shares the best homology to 
the known vertebrate GFRα1 proteins although several domains distinctive to the gene do 
not appear to be well conserved.  A cDNA of 762 bp for a putative medaka Gdnf of 253 
amino acids was similarly obtained and sequence analysis across species indicates that it 
is generally well conserved in the medaka.  Expression analysis suggests the presence of 
a currently unidentified binding ligand to Gfrα1 in the medaka brain and that Gdnf might 
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CHAPTER 1: INTRODUCTION 
 
1.1 Spermatogonial Stem Cells (SSCs) 
 Differentiation of germ cells in the testis originates from a constantly renewed 
small pool of stem cells, termed SSCs located at the basement membrane of the 
seminiferous tubules (Oakberg 1971; De Rooij 1973).  According to the model proposed 
by Huckins (1971) and Oakberg (1971), these stem cells are represented only by a 
discrete sub-population of type A spermatogonia cells or more specifically, Asingle (As) 
spermatogonia and numbered no more than 0.03% of the total number of germ cells 
(Tegelenbosch and de Rooij 1993).  Depending on the signals produced by the 
surrounding Sertoli cells, As spermatogonia will undergo mitosis to either renew 
themselves by forming two single stem cells or differentiate into Apaired (Apr) 
spermatogonia that remain connected by an intracellular bridge. The Apr spermatogonia 
will then divide into chains of four Aaligned (Aal) spermatogonia which themselves, will 
further divide into chains of 8, 16 and up to, although rarely, 32 cells.  Upon reaching this 
stage, the spermatogonia will give rise to more differentiated germ cells such as A1–A4 
spermatogonia, type B spermatogonia, and spermatocytes which will then ultimately 
undergo meiosis (Fig. 1) to form mature sperms. Although As, Apr and Aal are sometimes 
collectively referred to as undifferentiated spermatogonia, (Lin et al. 1993; De Rooij and 
Grootegoed 1998; De Rooij et al. 1999; Meng et al. 2000), the As spermatogonia are 
regarded as the true stem cells of spermatogenesis (Huckins 1971; Oakberg 1971; Lok et 
al. 1982; De Rooij 1998).  Due to the increasing amount of contradicting evidence in 
recent years, the A0 model put forth by Clermont and Bustos-Obregon (1968) and 
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Clermont and Hermo (1975) shall not be discussed in this paper.  For review, see De 




Fig. 1 Schematic diagram of spermatogonial multiplication and stem cell renewal.  
 
This scheme probably applies to all mammals except for humans (De Rooij 1983). Stem cells (As) 
proliferate, renewing the stem cell pool and also producing undifferentiated A type paired spermatogonia 
(Apr) which are joined together by intercellular cytoplasmic bridges. Further divisions of Apr produce chains 
of aligned spermatogonia (Aal). These differentiate through six mitotic divisions into A1, A2, A3, A4, 




1.2 Glial Cell Derived Neurotrophic Factor (GDNF) 
 GDNF is the founding member of a family of structurally related molecules, of 
which there are currently four members: GDNF, neurturin (NRTN) (Kotzbauer et al. 
1996), persephin (PSPN) (Milbrandt et al. 1998), and artemin (ARTN) (Baloh et al. 
1998).  Together, these factors form the GDNF-family ligand (GFL), a distinct subgroup 
of the transforming growth factor-β (TGF-β) superfamily.  Despite low amino-acid 
sequence homology, GDNF and other structurally characterized members of the TGF-β 
superfamily have similar conformations (Ibanez 1998); they all belong to the cystine-knot 
protein family, and they function as homodimers.   
 First isolated in 1993 and identified to be a potent survival factor for midbrain 
dopaminergic neurons in vitro (Lin et al. 1993), GDNF was soon discovered to have a 
much wider role in development.  It supports the survival of several neuronal populations 
including motor neurons (Henderson et al. 1994; Oppenheim et al. 1995; Yan et al. 1995), 
central noradrenergic neurons (Arenas et al. 1995), cerebellar Purkinjie neurons (Mount 
et al. 1995), peripheral sensory and sympathetic neurons (Buj-Bello et al. 1995), 
autonomic neurons in peripheral ganglia (Ebendal et al. 1995; Trupp et al. 1995) as well 
as dopaminergic neurons (Beck et al. 1995; Tomac et al. 1995), making it  a good 
candidate for treatment of dopaminergic neuron or motor neuron diseases such as 
Parkinson’s disease and amyotrophic lateral sclerosis.  More recently, it was also 
discovered to stimulate the proliferation of clusters of As spermatogonia and Apr 
spermatogonia, in vivo (Meng et al. 2000; Yomogida et al. 2003) and in vitro (Nagano et 
al. 2003; Kubota et al. 2004; Hofmann et al. 2005), hence establishing its central role in 
dictating the cell fate of SSCs.   
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1.3 GFL-induced activation of the protein tyrosine kinase, RET requires GDNF 
Family Receptor-α (GFRα) 
 Unlike typical members of the TGF-β superfamily, GFLs do not signals through 
receptor serine-threonine kinase.  Instead, it signals through a receptor complex formed 
by the receptor tyrosine kinase RET and a novel class of protein, known as GDNF Family 
Receptor-α (GFRα), which are linked and localized to the lipid rafts of the plasma 
membrane by a glycosylphosphatidylinositol (GPI) anchor. (For review, see Airaksinen 
and Saarma 2002).  Lipid rafts are lipid micro-domains constituted of sphingolipids and 
cholesterol within the plasma membrane and play important roles in cellular signaling.  
Recent evidences have indicated that lipid rafts are crucial for abundant biological events 
including growth factor-receptor signaling, cellular adhesion, synaptic transmission and 
membrane associated proteolysis (Brown and London 1998; Tooze et al. 2001). 
 GDNF binds to RET via GFRα1 (Jing et al. 1996) while NRTN, ARTN and 
PSPN use GFRα2, GFRα3 and GFRα4 as the preferred ligand-binding receptors 
respectively (Treanor et al. 1996; Baloh et al. 1997; Buj-Bello et al. 1997; Creedon et al. 
1997; Jing et al. 1997; Sanicola et al. 1997; Baloh et al. 1998; Enokido et al. 1998)., 
although alternative ligand-coreceptor interaction also appears to occur in culture.  
Studies have shown, at least in several occasions that NRTN is capable of signalling via 
GFRα1 in human (Baloh et al. 1997), mice (Widenfalk et al. 1997; Golden et al. 1998), 
rat (Creedon et al. 1997)and chicken (Homma et al. 2000), although GFRα2 is its 
preferred receptor.  ARTN had also been known to exhibit such similar behaviour (Fig. 2) 




Fig. 2 GDNF-family ligand interaction with their receptors. 
 
All GFLs activate RET tyrosine kinase via different GFRα receptors. Solid arrows indicate the preferred 
functional ligand-receptor interactions, whereas dotted arrows indicate putative crosstalk. GFRα proteins 
are attached to the plasma membrane through a GPI-anchor and consist of three (GFRα4 has only two) 
globular cysteine-rich domains joined together by adapter sequences.  (Modified from Sariola and Saarma, 
2003)  
 
 Upon stimulation by GDNF, the anchored GFRα1 will recruit RET to the lipid 
rafts (Fig. 3A-B) and such localization is thought to be critical for effective downstream 
signalling.  Any disruption to such localization would lead to acute attenuation in 
intracellular signaling events including neuronal differentiation and survival, even if RET 
is phosphorylated after GDNF stimulation (Tansey et al. 2000).  So, the lipid rafts seem 
to compartmentalize signalling molecules on both sides of the plasma membrane, which 
allows them to interact with each other and prevents interactions with proteins that are 
excluded from the rafts.   
 However, Ibanez and his colleagues soon demonstrate that unbound soluble 
GFRα1 can too recruits RET to lipid rafts (Fig. 3C) and mediates intracellular signaling 
events, albeit with delayed kinetics (Paratcha et al. 2001).  In addition, they also illustrate 
that RET which moves to the lipid rafts upon stimulation by GDNF triggers the signal 
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through FRS2 (fibroblast growth factor receptor substrate 2) while those that moves to 
the outside of the rafts trigger the signal through SHC (Src-homologous and collagen-like 
protein) (Fig. 3B).  Since SHC and FRS2 share the same tyrosine 1062 docking site in 
RET (Coulpier et al. 2002), this imply that differences in GDNF signalling through RET 
could lead to dramatically different cellular response although the mechanisms that bring 
the complex of GDNF, soluble GFRα1 and RET to rafts, and prolong signalling, are 
unclear at the moment.   
 Alternatively, GDNF could also signal independently of RET, by utilizing the 
neural cell adhesion molecule (NCAM) in collaboration with GFRα1.  (Paratcha et al. 
2003).  This binding will activate Fyn, a member of the Src family of cytoplasmic 
tyrosine kinases (Panicker et al. 2003), although it seems highly unlikely that this 











Fig. 3 Schematic illustration of initial signaling events mediated by the binding of GDNF to RET 
receptor complex in lipid rafts.   
 
(A) GFRα1 is anchored in the lipid rafts, while RET is located in the outside of lipid rafts in the inactive 
form. (B) GFRα1 recruits RET to lipid rafts upon the binding of GDNF to GFRα1 and the recruitment of 
RET to the lipid rafts results in the dimerization and activation of RET.  RET which moved to lipid rafts 
following GDNF stimulation triggers the signals through SNT/FRS2, while activated RET located outside 
of the rafts trigger the signal through SHC.  (C) Soluble GFRα1 with GDNF also recruits RET to lipid rafts 





Fig. 4. Schematic illustration of GDNF and GFRα1 signalling through NCAM.   
 
GDNF can signal independently of RET and utilizes NCAM instead. In this case, a Src-like kinase known 
as Fyn will be activated instead of FRS2 and SHC.  (Modified from Sariola and Saarma 2003).   
 
1.4 Medaka as a Model Organism 
 Medaka (Oryzias latipes) is a small (3cm to 4cm) egg-laying freshwater fish 
that is found primarily in Japan, Korea and China.  It has a short generation time of 2 
to 3 months, and a short life-span of 2 years.  Hardy and prolific, it can survive a wide 
range of temperatures (4°C to 40°C) and easily induced to spawn in captivity; when 
kept at an optimum temperature between 25°C to 28°C, spawning can be induced 
simply by light cycles (12hr light and 12hr dark).   
 Medaka can lay up to 30 to 50 eggs daily.  Transparent and synchronous in 
development, the eggs can then be staged under dissecting microscope to study early 
developmental process, fertilization and embryology.  In addition, being eurythermal 
in nature, early embryos can be maintained at temperatures as low as 4°C to slow 
down their development for up to 3 months.  This will be useful for transplantation and 
microinjection experiments.  Sperm can also be stored for stock preservation.   
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 With the ease of breeding and low susceptibility to common fish diseases, the 
maintenance of the medaka is easy, cheap and not space consuming, making medaka 
an ideal animal model source for carrying out research experiments.   
 However, it is the major advances in recent years that make medaka an 
increasingly popular candidate as a model organism.  Firstly, the establishment of the 
medaka embryonic stem cell-line (MES) had provided scientist with a unique tool for 
introducing targeted or random genetic alterations through gene replacement, insertional 
mutagenesis, and gene addition due to the possibility of in vitro selection for the desired, 
recombinant genotype (Hong et al. 1998).  Secondly, the successful generation of the see-
through medaka model with transparent body through out adult life (Fig. 5A) had allowed 
convenient, noninvasive studies of morphological and molecular events that occur in 
internal organs in the later stages of life (Wakamatsu et al. 2001).  Thirdly, the Medaka 
Genome Sequencing Project started in mid 2002 has already achieved a current status of 
draft assembly covering 91-99% of the genome and once completed, this comprehensive 
database will provide future investigator a powerful mean to identify and map genes 
rapidly.  Finally, the establishment of a normal medaka fish spermatogonial cell line (SG3) 
capable of test tube production (Fig. 5B) (Hong et al., 2004) will offer researchers a 
unique opportunity to study spermatogenesis in vitro and develop new approaches to 
germline transmission.   
 The major advantages and unique features of the medaka fish are summarized 
in Table 1, in comparison with the other 2 common fish models, zebrafish and Fugu.  
The evolutionary relationship between medaka and various other fish models is 
illustrated in Fig. 6. For additional details, see Wittbrodt et al. 2002 and Shima and 
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Mitani 2004, as well as to the ‘Medakafish homepage’ curated by H. Hori 
(http://biol1.bio.nagoya-u.ac.jp:8000/).   
 
 
Table 1 Biological characteristics and availability of experimental tools in three teleost species 
(Ishikawa 2000).   
 
Biological Characteristics  Zebrafish  Medaka  Pufferfish  
Genome size (Mb)  1700  800  400  
Chromosome number of 2n  50  48  42 
Sex determination  -  XY type  -  
Life cycle  3 months  3 months  -  
Outdoor breeding  No  Yes  Yes  
Crossing in lab  Yes  Yes  No  
Linkage map  Yes  Yes  No  
Information on sequenced 
genes, mapped genes and 
DNA markers  
Much  Much  Much  
Genetic information on wild 
populations  
None  Good  None  
The number of inbred strains  0  Many  0  
Cryopreservation of 
spermatozoa  
Yes  Yes  No  
Transgenic fish  Yes  Yes  No  
Chimeric fish  Yes  Yes  No  
Gynogenesis  Yes  Yes  No  
ES-like cells  No  Yes  No  
Active transposable 
elements  








Fig. 5 Recent advancement in medaka fish.  
 
(A) Picture of the unique see-through fish (Wakamatsu et al. 2001).  (B) Sperm from in vitro 






Fig. 6 Evolutionary relationships between fish models.   
 
This evolutionary tree illustrates that the last common ancestor of medaka and zebrafish lived more than 
110 million years ago. Notably, medaka is a much closer relative to Fugu than it is to zebrafish, or than 






 While full recapitulation of spermatogenesis has been achieved in vitro (Hong et 
al. 2004), the exact mechanism underlying the mitotic proliferation and differentiation of 
SSCs in medaka is still unclear.  The germ cell culture medium (GCM) used for 
sustaining the SG3 cell line includes a plethora of molecules extracted from the 7-day-old 
medaka embryos, and identification of specific growth factors in the medium involved in 
spermatogenesis remains elusive.  It would be interesting to see if the GDNF-GFRα1-
RET signalling pathway observed in other vertebrates to be conserved in the medaka.   
 Hence, the aim of this study was to clone and characterize both Gdnf and Gfrα1 
from the testis of the medaka fish via RT-PCR and RACE (Rapid Amplification of cDNA 
ends), so as to set the stage for future investigation into the GDNF-GFRα1-RET 
signalling pathway in medaka SSCs. The expression patterns of the genes in various 
tissues and embryonic stages will also be presented  
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CHAPTER 2: MATERIAL AND METHODS 
 
2.1 Fish Maintenance and Collection of embryos 
 Medaka (Oryzias latipes) was maintained in household aquarium and was fed 
with Artemia nauplii twice daily.  Temperature is maintained from 26°C to 29°C and 
under an artificial photoperiod of 14 hour light and 10 hour darkness.  No attempts was 
made to separate the males and females, and the ratio of males to female kept in each 
tank is roughly 2 : 3.   
 Embryos were collected in the morning and transferred into ERM (Embryo 
Rearing Medium) before incubating it at 27°C.  One liter of ERM has 1.0 g NaCl, 0.03 g 
KCl, 0.04 g CaCl2•2H2O, 0.163 g MgSO4•7H2O and 10 ml of Methylene blue.  The 
medium is changed daily and any embryos found dead will be discarded.   
 
2.2 RNA isolation from organs and embryos 
 Total RNA was extracted from several organs including, liver, intestines, muscle, 
brain, eyes, testis and ovary of the medaka fish with Trizol Reagent (Invitrogen) under 
the conditions suggested by the manufacturer.  The RNA was dissolved in RNase-free 
water by passing the solution a few times through a pipette tip and was incubated at 60°C 
for 10 min. The RNA samples were then stored at -80°C.   
 For embryos, the developmental stages were checked under microscope daily and 
RNA was extracted only from embryos at development stage 2, 7, 10, 22, 39 and 40 as 
determined according to Iwamatsu (2004). Conditions for extraction are similar to the 
organs.   
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2.3 cDNA synthesis 
 Total RNA isolated from tissues and embryonic stages were used to synthesize 
first strand cDNA and then served as template for PCR amplifications.  cDNA 
synthesis was carried out with Moloney Murine Leukemia Virus Reverse Transcriptase 
(M-MLV RT, Promega, USA) and 18-mer oligo dT according to the Manufacturer’s 
protocol.  Before cDNA synthesis, total RNA samples were treated by RNase-free 
DNase to eliminate any possible genomic or transfected DNA contaminations.   
 For RACE (Rapid Amplification of cDNA Ends), the cDNA template was 
synthesized according to the BD SMART™ RACE cDNA Amplification Kit User 
Manual and 1 µg of RNA was used per cDNA synthesis reaction. The synthesize 
cDNA was then diluted with 40ul of nuclease-free water for subsequent PCR reactions.   
 
2.4  cDNA cloning of medaka Gdnf and Gfrα1 by RT-PCR and RACE 
 Polymerase Chain Reaction (PCR) was performed with the designed primers to 
amplify a specific DNA fragment using Taq polymerase (Fermentas, USA) in a 
thermocycler. PCR was performed following general protocols in 25ul for detection and 
100ul for scaling up. Normal reactions were carried out as:  
Reaction mixture:  
14.85 µl  PCR-Grade water  
2.5 µl  10x PCR Buffer with (NH4)2SO4  
2 µl  MgCl2 (25 mM)  
2.5 µl  dNTP Mix (2 mM)  
1 µl  Template DNA (20ng)  
1 µl  Primer1 (5 mM)  
1 µl  Primer2 (5 mM)  




PCR was run for 25 to 40 cycles at 94°C for 15 sec, 56°C for 15 sec and 72°C for 60 
sec.  
 For RACE, PCR was carried out according to manufacturer’s specification with 
slight modifications. 4% DMSO was added to the reaction mixture and PCR was run 
for 35 cycles at 94°C for 20 sec, 68°C for 20 sec and 72°C for 4 mins instead.  
 Reagents and enzymes needed were purchased from Fermentas and thermocyclers 
from Applied Biosystem.  
 
2.5  Agarose gel electrophoresis  
 Agarose gel electrophoresis was used to separate and detect differentially 
molecular weighted DNA and RNA fragments.  Nucleotide fragments were separated 
by molecular filtering effect and visualized upon binding with ethidium bromide (EB) 
under UV light.  According to molecular size of DNA fragments to be separated, 
agarose concentration may vary from 0.7%-2.0%.  1×TAE was used as electrophoresis 
buffer.  Equipments used were ReadyAgarose
TM
 Precast Gel System (Bio-Rad, USA). 
DNA ladder (Promega, Fermentas) was added for estimating the molecular size of 
PCR products.   
50×TAE  2M  Tris-acetic acid  
 10mM EDTA (pH8.0)  
6×gel loading buffer  0.25 (w/v)  Bromophenol blue  
 0.25 (w/v) Xylene cyanol  






2.6  Recovery of DNA fragments from agarose gel  
 After electrophoresis, the desired gel band was excised, placed in a 1.5 ml 
Eppendorf tube and its weight determined.  Gel purification was performed using 
Ultraclean
TM 
15 DNA purification kit (Mobio, USA) and under conditions stipulated by 
the manufacturer.  The concentration of the recovered DNA was determined using a 
Shimadzu UV-160A spectrophotometer and then stored at 4°C until further use.   
 
2.7  Ligation of DNA fragment into pGEM-vector  
 After recovery of DNA fragment by gel extraction, the PCR products were ligated 
into pGEM-T Easy Vector (Promega) for cloning and sequencing.  The pGEM-T Easy 
Vector multiple cloning sites is flanked by recognition sites for the restriction enzyme 
EcoR1 which allows single enzyme digestion for the release of insert.  The ligation 
reaction mixture was set up according to manufacturer’s recommendations with slight 
modifications:   
5 µl  2x Rapid Ligation Buffer  
0.8 µl  pGEM-T Easy Vector (40 ng)  
3.2 µl  DNA fragment  
1 µl  T4 DNA Ligase (3 Weiss units/µl)  
 
 The reaction was mixed by pipetting and incubated overnight at 4°C.  
 
2.8 E.coli transformation  
 Transformation is a procedure to introduce circular plasmids into bacteria for the 
purpose of amplification.  The tubes containing the ligation reaction were centrifuged to 
collect contents at the bottom of the tube. 2 µl of ligation reaction was transferred to a 
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1.5-ml microcentrifuge tube on ice.  DH5α competent cells from -80°C storage prepared 
using the MgSO4 method (Nishimura et al. 1990) were thawed in an ice bath for about 5 
min and the content of the tubes were mixed gently by flicking.  50 µl of competent cells 
were added to the respective ligation reaction and the mixture were flicked gently and 
placed on ice for 30 min.  The cells were then heat shocked for 90 secs in a water bath at 
42°C, and the tubes were immediately returned to the ice for 2 min.  800 µl of Luria-
Bertani (LB) medium was added to the tubes containing the cells transformed with 
ligation mixture and incubated for 45 mins at 37°C.  During the incubation period, 30 µl 
of X-gal and 10 µl of IPTG were added to LB ampicillin (100µg/ml) agar plate for blue-
white selection.  After 1.5 h, the cells were pelleted at 3,000 rpm for 5 min, resuspended 
in 100 µl of LB medium and then plated. The plates were incubated at 37°C for 12 to 16 
hours.   
 After incubation overnight, the LB plates were stored at 4°C for 30 min to 
facilitate blue-white screening.  Individual colonies were then picked and incubated for 
14-16 h in 4 ml of LB medium.  
LB medium (20g/l)  10 g  Tryptone  
 5 g  Yeast extract  
 5 g  NaCl  
LB agar powder (40g/l)  10 g  Tryptone  
 5 g  Yeast extract  
 10 g  NaCl  
 15 g  Agar  
IPTG (20% w/v)  0.8 M  Isopropylthio-β-D-galactoside  






2.9 Digestion of DNA with EcoRI 
 Plasmid DNA was incubated at 37°C for 1-2 hours in a reaction mixture 
containing 1 µl Buffer, 3 µl plasmid DNA, 5 µl H2O and 1 µl of EcoRI (Invitrogen, USA).  
The digested plasmid DNA was then visualized on a 1% agarose gel under UV light.   
 
2.10 DNA sequencing and analyses  
 Upon confirmation of positive inserts by test digestion, DNA sequencing was 
performed using Big Dye Terminators v3.1 Cycle Sequencing Kit (ABI PRISM, USA).  
The total sequencing reaction is 5 µl and consist 1 µl DNA template, 1.5 H2O, 1 µl of 
M13 primer (3.2 pmol), 1.5 µl Big Dye (v3.1).  The PCR cycling condition was: 94°C for 
10 sec, 50°C for 5 sec and 60°C for 1 min.  The product was purified with 20 µl 
ethanol/sodium acetate solution from a stock solution consisting of 3 µl of 3M sodium 
acetate (pH 4.6), 62.5 µl of non-denatured 95% ethanol and 14.5 µl of deionized water.  
The tubes were vortexed briefly and left at room temperature for 15 min to precipitate the 
extension products.  The tubes were centrifuged at maximum speed for 20 min and the 
supernatants removed immediately.  500 µl of 70% alcohol was added to wash the pellets 
and mixed briefly.  The tubes were placed in the microcentrifuge in the same orientation 
and spun for 5 min at maximum speed.  The supernatant was then aspirated carefully and 
the samples left to dry under room temperature for about 15 mins.   
 12 µl of High Dye (ABI PRISM, USA) was added and reaction mixture was 
vortexed briefly. The samples were transferred to a 96 well plate for sequencing reaction 
using ABI 3100 automated DNA sequencers.  Nucleotide sequences obtained were 
processed and analyzed with commercial software DNAMAN and Vector NTI.   
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2.11 Expression Analysis of tissues and embryos 
 After cDNA synthesis, expression of Gdnf and Gfra1 transcript was analyzed 
according to the PCR conditions stipulated above for 35 cycles. β-Actin was used as 
calibrations (28 cycles).   
 
2.12 Medaka Genome Database 
 The medaka genome database is retrieved from 
http://dolphin.lab.nig.ac.jp/medaka and  the data provided freely by the National Institute 
of Genetics and the University of Tokyo for use in this publication only 
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CHAPTER 3: RESULTS AND DISCUSSION 
 
3.1 Isolation and characterization of medaka Gdnf.   
 As sequence alignments across several vertebrate species revealed significant 
amino acid conservation in GDNF, a tblastn was performed using the mouse homologue 
as a query against the medaka genome database.  From the blast results,  we were able to 
identify the putative medaka Gdnf to Scaffold 77, and after careful analysis of the 
genome sequence, two pairs of putative primers were designed; Forward 1, 5’–ATGAA-
GTATGGGATGTTTTGGC-3’; Reverse 1, 5’-CTCATGTCCAGTGTTTGGTCAA-3’; 
Forward 2, 5’-GACGAAGAGCCACTGTTCCAGCGCAAGG-3’; Reverse 2, 5’-CTGG-
TATCCCAGCCCCAAATCCGTCACA-3’ (Fig. 7).   
 Using the primers, part of the gene was successfully isolated and the medaka gdnf 
was found to contain a putative ORF (Open Reading Frame) of 762 bp, encoding for a 
protein of 253 aa (amino acids) residues (Fig. 7) and a predicted molecular weight of 30 
kDa.  The partially isolated Gdnf was then blast with our internal EST (Expressed 
Sequence Tag) database (data not shown) and a leader sequence of approximately 749 bp 
was uncovered (Fig. 7).  The 5’ UTR was subsequently confirmed by two additional 
primers (data not shown); Exon 1, 5’-CTGCTTTTCAGTGCAGTTGGAGC-3’; Exon 2, 
5’-CATACACCAGATAAAGTGTGGATCAG-3’.   
 Similar to the mice (Matsushita et al. 1997) and rat cDNA (accession number. 
AJ011432), an additional in frame ATG codon 36 bp upstream of the predicted start 
codon was also discovered.  Although direct experimental evidence, at least in the case of 
mice (Matsushita et al. 1997) had demonstrated that this ATG codon is not the translation 
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start point, it is unclear if this is also true in the medaka.  The rest of the ATG detected 
upstream are out of frame and yield short peptide sequences not exceeding 70 aa.  Hence, 




-197  ctgaaaactgcgctcccccaaaccaggatccaggggtgttttggagagatgagtggacgtctgttactcactactctcgttgagatctataaaagaggg 
               TATA Box 
-98       gcggacacaaactcccatcaaacgtcagagcgcactaaactataaatctctccaagcagcgctgtgcgcccggtgttgtgatatgcgcagacatctgtc 
          GC-Box               ATF/CREB     TATA Box 
1         CTGCTTTTCAGTGCAGTTGGAGCGCGGCGCGCATGGACACTCCACGCAGGGAATGGAGAATGAGATGTTTACCACGTCAAGATTAGTTTGAGAAGCTTT 
100       TTTTTGTTGTTTATTCAGGATAAAGGGGCGTTTTTGGTTGTTTTGTTGAGGGGTTATTAATTTGGGGGGAAACGGACAACTTTTACGCTTCACTTTGTG 
199       TGCTGGAGACACCGATGTCTTCATTAGGCTCCTCTCAACCGGAGATGGTGGATCTCTCTCGGATTTCCAGCCCGGAAACGTAGCGTCCAATTTTTAAGC 
298       GACTGAAGCCCCGCAAGGCACAGTGGCACTCGGTCCACTGCCTCCTACACCTCGCCTTGGATTGGACTCCTACGAGACTGGTCACTGGAGAGAGACGCA 
397       TGGTTTGCTCGAAACGCAGGGTCGGATTGTGAAAAACTGGCACATTACCTATAGCCTATCTGTTTTTCTTTCTTTTCCTTTTTTGTTTGGACTAAAGCT 
496       GAATTTGACCCCGCTCTGGGGACATTTGCTCATCGATGTTTTTGAAATATTTCACCCAGCCAAGTCAGCTGGGGACGCTAAACGAAATGTGTTTTCTGT 
595       TTGGATTGTAACACCAACAGTCAAGCGAGTTTTAAGTCATGATGGGGCATATGTAAGCATACACCAGATAAAGTGTGGATCAGAGCCTCTTGACATGAT 
694       GACACAGTTATTAATACAGAATGAATTGGGCTTTCTTTATAGGAACTGAGTCTAAAATGAAGTTATGGGATGTTTTGGCCACGTGTTTGTTGCTGCTGA 
1                                                                  M  K  L  W  D  V  L  A  T  C  L  L  L  L    
793       GCTCTGTTGCTACAAGGCCTCTTTACCAAAGCACTCATCCAGCCAAGAGGACTTACTTTCCCAGCAGCAGTCATCCTGCGTCCCTGTCTGTGGAAGACG 
15        S  S  V  A  T  R  P  L  Y  Q  S  T  H  P  A  K  R  T  Y  F  P  S  S  S  H  P  A  S  L  S  V  E  D    
892       AAGAGCCACTGTTCCAGCGCAAGGAGCGCAAACTGAAAGATATCTCAATGGAGGATCAGTATGATGCTGCAGGTTTCTACCCTGAGCAGTTTGAGGATG 
48        E  E  P  L  F  Q  R  K  E  R  K  L  K  D  I  S  M  E  D  Q  Y  D  A  A  G  F  Y  P  E  Q  F  E  D    
991       TGATGGATTTTATCGAGGCGACCATCAGCAGGCTGCGGAGGTCATCGGAACCCGCCATTGGCTCCAGAGGCCGGCGGGAGCAGAAGCAGAGAAAAGCAG 
81        V  M  D  F  I  E  A  T  I  S  R  L  R  R  S  S  E  P  A  I  G  S  R  G  R  R  E  Q  K  Q  R  K  A    
1090      CAAACACGGGAGGCAGAAGAGAGGAAGGCAGAGGGCACGGAGTCAAGAGGAAGAGTAGAGGTCGTGGGGGAGGTCGCGGCAGCAAAGGAGGCAGAGGCG 
114       A  N  T  G  G  R  R  E  E  G  R  G  H  G  V  K  R  K  S  R  G  R  G  G  G  R  G  S  K  G  G  R  G    
1189      ACAAGGGAAAGGAGGGGATATACGTTCAGAGCCGAGGTTGCCTGCTGAAGGAGGTCCACCTCAATGTGACGGATTTGGGGCTGGGATACCAGACTAAGG 
147       D  K  G  K  E  G  I  Y  V  Q  S  R  G  C  L  L  K  E  V  H  L  N  V  T  D  L  G  L  G  Y  Q  T  K    
1288      AGGAGCTGATATTCCGATACTGCAGCGGCCCCTGCGCCGAGGCGGAGACCAACTACGACAAGATCCTGAACAACCTCACACACAACAAAAAGCTAGACA 
180       E  E  L  I  F  R  Y  C  S  G  P  C  A  E  A  E  T  N  Y  D  K  I  L  N  N  L  T  H  N  K  K  L  D    
1387      AAGACACGCCCTCGCGCACCTGCTGCCGCCCAATTGCATTCGATGACGACCTGTCCTTTTTGGACGACAACGTGGTGTATCACACCCTGAAAAAGCATT 
213       K  D  T  P  S  R  T  C  C  R  P  I  A  F  D  D  D  L  S  F  L  D  D  N  V  V  Y  H  T  L  K  K  H    
1486      CAGCCAGGAAGTGCGGCTGTGTTTGACCAAACACTGGACATGAG 
246       S  A  R  K  C  G  C  V  *   
 
Fig. 7 Nucleotide sequence and deduced amino acid sequence of medaka gdnf.   
 
The genomic sequence is depicted in lowercase, the cDNA in uppercase and the deduced amino acid 
protein sequence in blue and boldface.  The four putative promoter elements are underlined and its 
corresponding identity listed underneath.  The ATG indicated by a box is unlikely to be the translation start 
point although it is capable of yielding a polypeptide 265 aa long. The start and stop codon of gdnf is more 
likely to be the red ATG and TGA, respectively instead.  The primers used to clone the gdnf CDS is 
highlighted in grey while those used for mRNA expression analysis in yellow.  The primers in green are 
obtained only after blasting the cloned CDS with our internal EST database. The arrow indicates the 
direction of the primers.   
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 A scan through the genomic sequence immediately preceding the predicted 5’ end 
of the cDNA revealed 3 distinct putative promoter elements; a GC-Box, a CREB site and 
surprisingly, two TATA box, all localized within 150 bp upstream of the predicted exon 1.  
It is difficult to determine the true binding site for TFIID (Transcription Factor II D), 
although both TATA box might well be functional, with each of them responding to only 
a certain distinct set of transcriptional signals.  Interestingly, the promoter sequence of 
the human homologue also contains a TATA box, a GC box and a CREB site although it 
has two additional NF-A1-like binding sites (Grimm et al. 1998).  Taken together, it is 
very likely that the transcriptional control mechanism in medaka gdnf to be very similar 
to the human Gdnf.   
 Although sequence alignment using Vector NTI shows that the medaka Gdnf only 
shares 64%, 52%, 50% and 49% homology with its zebrafish, human, mice and rat 
counterpart respectively, all functionally identified motifs found within other vertebrates 
appear to be well conserved in the medaka (Fig. 8a).  The consensus sequence RXK/RR 
for proteolytic processing by furin (van de Ven et al. 1990) in the constitutive secretion 





the potential secretion signal from Lys2 to Thr19.  In addition, all eight cysteine residues 
and two putative conserved N-linked glycosylation sites appears conserved (Fig. 8a).  
Sequence comparison by BLAST did not reveal significant homology to any other known 
proteins.  The phylogenetic tree of Gdnf proteins from medaka and other organisms 




          1       *                         I                              ▼              
Ol   (1) MKLWDVLATCLLLLSSVATRPLYQSTHPAKRTYFPSSSHPASLSVEDEEPLFQRKERKLKDISMEDQYDAAGFYPEQFED 
Dr   (1) MKLWDILATCLLLLSSVSTRPLFHKLQPSKRAVVRSESPALDPIIDS-----QPETSNPKQASMEEQYDLTGLYPEQFED 
Hs   (1) MKLWDVVAVCLVLLHTASAFPLPAGKRPPEAPAEDRS-----------------LGRRRAPFALSSDSNMPEDYPDQFDD 
Mm   (1) MKLWDVVAVCLVLLHTASAFPLPAGKRLLEAPAEDHS-----------------LGHRRVPFALTSDSNMPEDYPDQFDD 
Rn   (1) MKLWDVVAVCLVLLHTASAFPLPAGKRLLEAPAEDHS-----------------LGHRRVPFALTSDSNMPEDYPDQFDD 
                   2                        II                                          * 
Ol  (81) VMDFIEATISRLRRSSEPAIGSRGRREQKQRKAANTGGRREEGRGHGVKRKSRGRGGGRGSKGGRGDKGKEGIYVQSRGC 
Dr  (76) VMDFIEATLGRLRRSSDVEPQMKRDRVRQKAAANTE---KSGGRGRGERKRSRGR------ARSRDDRVK-G---QGRGC 
Hs  (64) VMDFIQATIKRLKRSPDKQMAVLPRRERNRQAAAAN------------PENSRG-------KGRRGQRGK------NRGC 
Mm  (64) VMDFIQATIKRLKRSPDKQAAALPRRERNRQAAAAS------------PENSRG-------KGRRGQRGK------NRGC 
Rn  (64) VMDFIQATIKRLKRSPDKQAAALPRRERNRQAAAAS------------PENSRG-------KGRRGQRGK------NRGC 
   ∆       *  *        ∆   ** 
Ol (161) LLKEVHLNVTDLGLGYQTKEELIFRYCSGPCAEAETNYDKILNNLTHNKKLDKDTPSRTCCRPIAFDDDLSFLDDNVVYH 
Dr (143) LLKEIHLNVTDLDLGYRTKEELIFRYCSGPCHDAETNYDKILNNLTHNKKLDKDTPSRTCCRPIAFDDDISFLDDSLEYH 
Hs (119) VLTAIHLNVTDLGLGYETKEELIFRYCSGSCDAAETTYDKILKNLSRNRRLVSDKVGQACCRPIAFDDDLSFLDDNLVYH 
Mm (119) VLTAIHLNVTDLGLGYETKEELIFRYCSGSCESAETMYDKILKNLSRSRRLTSDKVGQACCRPVAFDDDLSFLDDNLVYH 
Rn (119) VLTAIHLNVTDLGLGYETKEELIFRYCSGSCEAAETMYDKILKNLSRSRRLTSDKVGQACCRPVAFDDDLSFLDDSLVYH 
     * * 
Ol (241) TLKKHSARKCGCV  100% 
Dr (223) TLKKHSAKKCACV  64% 
Hs (199) ILRKHSAKRCGCI  52% 
Mm (199) ILRKHSAKRCGCI  50% 




Fig. 8 Sequence comparison of medaka Gdnf and its orthologues 
 
(a) The first and second exons are indicated as I and II respectively while ▼ demarcate exon-intron 
boundaries.  Box 1 indicates potential secretion signal while Box 2 indicates the consensus sequence for 
proteolytic processing.  The N-linked glycosylation sites are indicated by ∆ and asterisks mark the 
conserved cysteine residues.  Percent identity values between medaka Gdnf and its homologs are indicated 
at the end.  (b) Phylogenetic tree of Gdnf proteins from medaka and other organisms.  Bootstrap values at 
branching are given.  The corresponding accession number is indicated after the species name.  Ol, Oryzias 
latipes; Dr, Danio rerio; Hs, Homo sapiens; Mm, Mus Musculus; Rn, Rattus norvegicus.   
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 While the medaka gdnf has four exons (Table 2), its CDS is made up of only two.  
The first two exons are part of its 5’ UTR and like its human counterparts, the start codon 
is located at exon 3 (Grimm et al. 1998).   However, in humans, there seems to be an 
additional level of control in the regulation of GDNF expression through the alternate use 
of exons; exon 1 and 2 are mutually exclusive and hence, human GDNF has only 3 exons 
(Fig. 9).   
 
 






Exon 5’- 3’ end Exon 
Size 
(bp) 
Intron 5’-3’ end Intron 
Size 
(bp) 
1 1194182-1194832 CTGCTTTTCA-CATATGTAAG 651 gtaaggatgg-gtgttcacag 557 
2 1195390-1195461 CATACACCAG-ATGAATTGGG 72 gtacgtttaa-tctttcacag 111 
3 1195573-1195800 CTTTCTTTAT-GAGGATCAGT 228 gtaagcagac-tgccttttag 3404 
4 1199205-1201900 ATGATGCTGC-ACGAAAGAGT 2696?   
 





Fig. 9 Schematic diagram of medaka gdnf gene structure in comparison to human.   
 
Untranslated exons are showed in grey box, translated exon in filled box and introns as solid lines.  The 
human Gdnf gene has two reported isoforms; the longer isoform (Accession Number: NM_000514) utilize 
exon 1 while the shorter isoform (NM_199231) utilize exon 2.  In medaka however, both exons appears to 
be included in the gdnf cDNA and not mutually exclusive.  Diagram is drawn to scale except for the last 




    1                      2 3                                                                                        4 
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3.2 Isolation and characterization of the medaka Gfrα1.   
 Likes its ligand, a tblastn was also performed using the mouse homologue as a 
query.  Similarly, two pairs of primers were designed from the scaffold; Forward (RACE), 
5’-GACATCTTCCGCTTGGCTCCCATCAT-3’; Reverse (RACE), 5’-ACTCCACTGTA-
GGCTTCATTGAGGGTCG-3’; Forward (Nested-RACE) 5’-GGGTGTCTGCCTCTGA-
GGTCTGCAAC-3’; Reverse (Nested-RACE), 5’-TTGCTGGTAAAGTCCAACAGTC-
GTGA-3’.   
 After obtaining the partial sequence of Gfrα1 through RT-PCR, the 5’ and 3’ end 
of the mRNA was subsequently determined by RACE.  The mRNA was 2551 bp long 
and translation of the nucleic acid in six frames locates the start codon to the 251st 
nucleotide; the rest of the ATG codons failed to yield peptide longer than 150 aa.  Hence, 
the open reading frame of Gfrα1 is predicted to be 1401 bp long, encoding for 466 aa and 
with a theoretical molecular weight of 52 kDa (Fig. 10).  The sequence was further 
verified by the following primers; Forward, 5’-AAAGCAGAGGAATAAAGAGAAGT-
G-3’; Reverse, 5’-TTAATGTATAAAAATGATA-CAAAGCAT-3’.   
 Similarly to Gdnf, a scan through the genomic sequence was performed and two 
promoter elements were detected upstream of exon 1; A CREB site and one putative NF-
A1-like binding sites were localized at -300 and -581 bp, respectively.  No TATA box 
was detected although its presence might be masked by ten unresolved nucleotide 
sequence localized at -85 to -75 region of the genomic sequence (Fig 10).  
Transcriptional control of the gene is not well understood in human although the putative 
promoter elements identified might hint at a control mechanism similar to GDNF.   
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-593      aaggatgaaaatgaacaacaatcttcagattttacgaaatgaataaataaaaaaaaatgctgtaaatcagctcattgaggatgtaagctctctcaggta 
              NF-A1 like 
-494      gcagcagccatggcgctctgtgggtttgttaattagctattattgacttaaaatgttgattttctgtggagtcaatgagtggactctggagtttaaacc 
-395      ctctttgacacgctctctgtttttaaatccaccatttggctgtttttagatcattactgttgttaattggctctatttcatgatcattgcgcgcatgac 
-296      gtcacagcccccgtgcgctgcaccttgcgcttctctgctccgagttctcaccacactgttggacagttctgatcaaactgcgcagagtctccttcatct 
          ATF/CREB 
-197      gcttcgcggaatgtatttttcaggttttggaacattgaattattcccctctcgactcaatttttgctccaaaatattaaacttccttgaaaaatttccg 
-98       agtgtttttccctttnnnnnnnnnngagggtttttccctttttttttttttttaagtttcatcactcagagacatccggacactgtcggattacgcggc 
                         TATA box? 
1         AAAGCAGAGGAATAAAGAGAAGTGGGGACAGTCAGCCTGAAGGCGCGCTGCCTCATGTTTCCCCATCCGCTTTGTCCATCATCCAAAAAGTGCAGCGCG 
100       GTTTCAGCTGCTGGAGGACGCGTGGATTTGTCAGTGTCAGCTGCGCAGAATGCATCTTCACCTGAGACCTCAAATATGCAGCGCGAGGAAGAGTGGACC 
199       AGTCTGACAAGTTTGCTTTAACTGGGAAAACACCTGTTCATTTGGGGGCGCAATGATTTTAACTTTTGTCATCATTTTGTCCTTCACGGATTCGGTGTT 
1              M  I  L  T  F  V  I  I  L  S  F  T  D  S  V  F  
298       CACCTTGAAGGATGACCACGGCTCCCCTCGGCTGGACTGCGTAAAGGCCAGCAAACAATGCCTGAAGGAGAACGCGTGCAGCACCAAGTACCGGACGAT 
17          T  L  K  D  D  H  G  S  P  R  L  D  C  V  K  A  S  K  Q  C  L  K  E  N  A  C  S  T  K  Y  R  T  M  
397       GAGGCAGTGCGTAAAGGGGAGGGAGAGCAACTTCAGCGCGGTCACCGGTCCCGAGGCGCAGGGTGAATGCCTGAGCGCCATAGATGCCATGAAGCAGAG 
50          R  Q  C  V  K  G  R  E  S  N  F  S  A  V  T  G  P  E  A  Q  G  E  C  L  S  A  I  D  A  M  K  Q  S  
496       CCCCCTGTACAACTGCAGGTGCAGGAGAGGCATGAAGAAGGAGAAGAACTGCCTAAGGATCTTTTGGAGCTTGTTTCAGAGCTTGCATGGTAATGATTT 
83          P  L  Y  N  C  R  C  R  R  G  M  K  K  E  K  N  C  L  R  I  F  W  S  L  F  Q  S  L  H  G  N  D  L  
595       ACTGGAATACTCCCCGTACGAGCCAGTCAATAGCCGGCTCTCAGACATCTTCCGCTTGGCTCCCATCATAGCTGTCGAACCTGCATCTGCGAAGGAAAA 
116         L  E  Y  S  P  Y  E  P  V  N  S  R  L  S  D  I  F  R  L  A  P  I  I  A  V  E  P  A  S  A  K  E  N  
694       CAACTGTCTGAATGCCGCCAAAGCCTGTAACCTGAATGACACTTGTAAGAAGTACCGCTCGACTTACATCAACTCCTGCACCAGCAGGGTGTCTGCCTC 
149         N  C  L  N  A  A  K  A  C  N  L  N  D  T  C  K  K  Y  R  S  T  Y  I  N  S  C  T  S  R  V  S  A  S  
793       TGAGGTCTGCAACAAGCGCAAATGTCACAAGGCCCTGCGAGAGTTCTTTGACAAGGTTCCAAGTAAATACAGCTATGGGATGCTGTTTTGCTCCTGCCC 
182         E  V  C  N  K  R  K  C  H  K  A  L  R  E  F  F  D  K  V  P  S  K  Y  S  Y  G  M  L  F  C  S  C  P  
892       GGCAGAGGATCAGAAGGCCTGTGCAGAACGCAGGCGACAGACCATCGTTCCCGTCTGCTCCTATGAAGATAAAGACAAGCCCAACTGTCTGTCCCTGCA 
215         A  E  D  Q  K  A  C  A  E  R  R  R  Q  T  I  V  P  V  C  S  Y  E  D  K  D  K  P  N  C  L  S  L  Q  
991       GAACACCTGCAAAACCAACTACATATGCAGGTCACGACTGTTGGACTTTACCAGCAACTGTCAGCCCGAGGTTCATTCCATATCCGGCTGCTTCACAGA 
248         N  T  C  K  T  N  Y  I  C  R  S  R  L  L  D  F  T  S  N  C  Q  P  E  V  H  S  I  S  G  C  F  T  E  
1090      GAACTATGCGGACTGCCTGCTAGCGTACTCCCGTCTTATTGGGACGGTGATGACGCCCAATTACGTGCAGTCGGCTGGCATCAGCCTGTCGCCGTGGTG 
281         N  Y  A  D  C  L  L  A  Y  S  R  L  I  G  T  V  M  T  P  N  Y  V  Q  S  A  G  I  S  L  S  P  W  C  
1189      TGACTGCAGCAGCAGTGGAAACAGCAAGCAAGACTGTGAGAAATTTGCTCAGTTTTTCACCGACAATCGCTGCCTGCGTAACGCCATCCAGGCATTTGG 
314         D  C  S  S  S  G  N  S  K  Q  D  C  E  K  F  A  Q  F  F  T  D  N  R  C  L  R  N  A  I  Q  A  F  G  
1288      CAACGGTACTGACGTCAGCATGTGGCATCCCCGACCCTCAATGAAGCCTACAGTGGAGTCGGGCATAAGTCGAAGGACTAAAGCCCGATTGAAGAACGT 
347         N  G  T  D  V  S  M  W  H  P  R  P  S  M  K  P  T  V  E  S  G  I  S  R  R  T  K  A  R  L  K  N  V  
1387      CCTGGACACGCTGACAAATGTGGCCAAGCTGGAAGACTCATACGGCATCTGCGAAACCTTACAGGCCCAAAAGCTGGTGTCAAATCAAACAGTGGACAT 
380         L  D  T  L  T  N  V  A  K  L  E  D  S  Y  G  I  C  E  T  L  Q  A  Q  K  L  V  S  N  Q  T  V  D  M  
1486      GGCTCCTTGTCTGAACCATCACCTGGAGGAGTCCGGGACTTTAAATGCCATTTCCAAAAGCTCCCCAGCAGGGCTCCTCTGCTCACAGTCGCCAGTCCT 
413         A  P  C  L  N  H  H  L  E  E  S  G  T  L  N  A  I  S  K  S  S  P  A  G  L  L  C  S  Q  S  P  V  L  
1585      GCTCCTCACTCTGGCCTTCACCTTCACTCTAACAGAATCACAAATCAAAGTTTTCCAGCTCTTGTAGGGAAAGGACTGACGATGGACCCTCCTTATCTC 
446         L  L  T  L  A  F  T  F  T  L  T  E  S  Q  I  K  V  F  Q  L  L  * 
1684      CGGAAGTAATCAAACCGCATTCCATGTAAAGAATTTCTCAAAGTGCAGCAACACTTTTTTTGTGGTCATAGCAGTGAAATCAGATGCTGTTGTGGATTG 
1783      ACATTTTTTTGGATGTCTTGTTGCAGAAAAACAGACTTGATGAATCTGTTGCTCAGACGTCAGCTCATTTACTTTCTGTGCCCCGTGGGAGCAGTTTGA 
1882      CTCCCAAAACTGTTTGGGAGCACTCGTGTCCCGGAGATAAAACTTCCCTCTGATGTGAAACATGTCATTTCTTTTGCGGCGCGTGTCACGCCAACGTTC 
1981      TGAATAGTGTTTTGAGTGTCGAGTTAATTGCTTGTTTGGATCTGTTGTGGTACCATGCCTGCTTAAGTGAGGGCTTGTAGAAGGAGTTAAGAATAATTT 
2080      GACACAAACTGAGCTCACCTTGGAGTCCAATTTATGTCTACAAAGGACGAGGGAAAACAACCGTCTTCTACATGTTTGGTCTTAGCAATAGATCAGGTT 
2179      TGTAGGTTTTGTTGTCATGGTGATATGTGGCTTTATCACCTCTTAAAGGACATTTTGTACATTTCTAACATGAGTGCTCTCTGTCTCTGTAAGGCTGCT 
2278      GTTAGATTGTGATCATTTGTCTGTAATATTCTGAAGTTTGTGCAGGTGGGAGCCTCAGCTTTACCCAAACGTTACACAGGATGTGACTGTTCTCTTTCA 
2377      ATGTGGTCACAAATATCACTTTGTTGTGCGATTATGTCAAGTTTGATAGTTGCACAACGATATCCTGAACAAAATTTCCTGTTAAATATCTGAAACATA 




Fig. 10 Nucleotide sequence of the PCR product and deduced amino acid sequence of medaka Gfrα1.   
 
The genomic sequence is depicted in lowercase, the cDNA in uppercase and the deduced amino acid 
protein sequence in blue and boldface.  The two putative promoter elements are underlined and its 
corresponding identity listed underneath.  The presence of a TATA box remains debatable due to ten 
unresolved nucleotide sequence at the -85 to -75 region of the genomic sequence.  The boxed ATG and 
TGA are the predicted start and stop codon of gfrα1, respectively.  The four amino acids in red at the C-
terminal are hydrophilic residues found on a supposing stretch of hydrophobic residues.  The primers used 
for gfra1 cDNA cloning are highlighted in grey while those used for mRNA expression analysis in yellow.  
Putative primers initially designed from the medaka genome draft database are highlighted in cyan.  The 
arrow indicates the direction of the primers.   
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 A search of the NCBI database using the BLAST algorithm reveals that the 
medaka gene is most similar to other Gfrα1 homologues.  Sequence alignment of amino 
acid sequence using vector NTI reveals medaka Gfrα1 shares 62% and 61% homology 
with the zebrafish paralogue pair, Gfrα1a and Gfrα1b, respectively while a lower identity 
value of 56%, 55% and 53% with human, mice and rat orthologues respectively (Fig. 
11a).   
 Unlike medaka Gdnf, not every functionally identified motifs found within other 
vertebrates appear to be well conserved in the medaka Gfrα1.  The three characteristic 
functional domain of GFRα1, namely the N-terminal hydrophobic domain representing a 
secretory signal peptide, GPI signal peptide and the C-terminal hydrophobic region could 
not be determined in the medaka as the corresponding regions shows poor homology in 









 were located in a supposing stretch of 
hydrophobic residues (Fig. 10).  However, the number of cysteine residues in the receptor, 
like other homologues, remains constant at 31 although the last residue, Cys
439
 fails to 
align properly to its counterparts.  Three putative N-glycosylation sites also appear to be 
conserved.  The phylogenetic tree of Gfrα1 proteins from medaka and other organisms is 




      I        ▼       *    *  *         *      ∆ 
 Ol GFRa1   (1) --------MILTFVIILSFTDSVFTLKDDHGSP----RLDCVKASKQCLKENACSTKYRTMRQCVKGRESNFSAVTGPEA 
Dr GFRa1a   (1) -------MFIAAIYIILPLLDVLLSAEESYFSSSN--RLDCVKANELCLKEPGCSSKYRTMRQCVAGRESNFSMATGMEA 
Dr GFRa1b   (1) MDLNKATMIFATFWIMFPVLDLVHFSKADAIAQSRSVRLDCVRAHEQCLGKYGCSTKYRTMRQCVAGRTGNFSMKGEPEA 
 Rn GFRa1   (1) -------MFLATLYFALPLLDLLMSAEVSGGDR-----LDCVKASDQCLKEQSCSTKYRTLRQCVAGKETNFSLTSGLEA 
 Hs GFRa1   (1) -------MFLATLYFALPLLDLLLSAEVSGGDR-----LDCVKASDQCLKEQSCSTKYRTLRQCVAGKETNFSLASGLEA 
 Mm GFRa1   (1) -------MFLATLYFVLPLLDLLMSAEVSGGDR-----LDCVKASDQCLKEQSCSTKYRTLRQCVAGKETNFSLTSGLEA 
           *  II     * *    *         ▼  III      ▼ 
 Ol GFRa1  (69) QGECLSAIDAMKQSPLYNCRCRRGMKKEKNCLRIFWSLFQSLHGNDLLEYSPYEPVNSRLSDIFRLAPIIA----VEPAS 
Dr GFRa1a  (72) KDECRLVLDALKQSPLYNCRCKRGMKKEKNCLRIYWGIYQHLQGNDLLEDSPYEPVNSRLSDIFRLAPIYS----GEPAL 
Dr GFRa1b  (81) QDECRNAIESMKQSPLYDCKCRRGMKKEKNCLRIFWSIYQSLQANDLLEDSPYEPVNSRLSDIFRLAPIIS----GEAAF 
 Rn GFRa1  (69) KDECRSAMEALKQKSLYNCRCKRGMKKEKNCLRIYWSMYQSLQGNDLLEDSPYEPVNSRLSDIFRAVPFISDVFQQVEHI 
 Hs GFRa1  (69) KDECRSAMEALKQKSLYNCRCKRGMKKEKNCLRIYWSMYQSLQGNDLLEDSPYEPVNSRLSDIFRVVPFISDVFQQVEHI 
 Mm GFRa1  (69) KDECRSAMEALKQKSLYNCRCKRGMKKEKNCLRIYWSMYQSLQGNDLLEDSPYEPVNSRLSDIFRAVPFISDVFQQVEHI 
              *      *     *     IV   *     * *   ▼          * *       * 
 Ol GFRa1 (145) AKENNCLNAAKACNLNDTCKKYRSTYINSCTSRVSASEVCNKRKCHKALREFFDKVPSKYSYGMLFCSCPAEDQKACAER 
Dr GFRa1a (148) AKENNCLNAAKACNLNDTCKKYRSAYISPCTSRVSTAEVCNKRKCHKALRQFFDKVPPKHSYGMLYCSCPLGDQSACSER 
Dr GFRa1b (157) TKDNNCLNAAKACNLNDTCKKYRSLYISPCTSRVSTTEVCNKRKCHKALRQFFDKVPPKHSYGMLFCSCPSGDHSACSER 
 Rn GFRa1 (149) SKGNNCLDAAKACNLDDTCKKYRSAYITPCTTSMSN-EVCNRRKCHKALRQFFDKVPAKHSYGMLFCSCR---DIACTER 
 Hs GFRa1 (149) PKGNNCLDAAKACNLDDICKKYRSAYITPCTTSVSN-DVCNRRKCHKALRQFFDKVPAKHSYGMLFCSCR---DIACTER 
 Mm GFRa1 (149) SKGNNCLDAAKACNLDDTCKKYRSAYITPCTTSMSN-EVCNRRKCHKALRQFFDKVPAKHSYGMLFCSCR---DVACTER 
         *    V    *      *     *▼        *         *   VI  *       ▼  
 Ol GFRa1 (225) RRQTIVPVCSYEDKDKPNCLSLQNTCKTNYICRSRLLDFTSNCQPEVHSISGCFTENYADCLLAYSRLIGTVMTPNYVQS 
Dr GFRa1a (228) RRQTIVPACSYEDKERPNCLTLQVSCKTNYICRSRLADFFTNCQPEPLSLSGCLKENYADCLLSYSGLIGTVMTPNYLRS 
Dr GFRa1b (237) RRQTIVPACSYEDKEKPNCLSLQASCKTNYICRSRLADFLTNCQPEARSISGCLKENYADCLLAYSGLIGTVMTPNYLRA 
 Rn GFRa1 (225) RRQTIVPVCSYEERERPNCLSLQDSCKTNYICRSRLADFFTNCQPESRSVSNCLKENYADCLLAYSGLIGTVMTPNYVDS 
 Hs GFRa1 (225) RRQTIVPVCSYEEREKPNCLNLQDSCKTNYICRSRLADFFTNCQPESRSVSSCLKENYADCLLAYSGLIGTVMTPNYIDS 
 Mm GFRa1 (225) RRQTIVPVCSYEERERPNCLNLQDSCKTNYICRSRLADFFTNCQPESRSVSNCLKENYADCLLAYSGLIGTVMTPNYIDS 
         * *    VII  *      * ▼        ∆       VIII 
 Ol GFRa1 (305) AGISLSPWCDCSSSGNSKQDCEKFAQFFTDNRCLRNAIQAFGNGTDVSMWHPRP-SMKPTVESGISR--RTKARLKNVLD 
Dr GFRa1a (308) PKISVSPFCDCSSSGNSKEECDRFTEFFTDNACLRNAIQAFGNGTDVSVWHPMPPVQTTTSMTTPSQRARDKDRSPNAIE 
Dr GFRa1b (317) PGISVSPWCDCSNSGNGKAECDKFTEFFTNNRCLRNAIQAFGNGTDVGVWQPQPPIMSTPADPYTPP--KGRDRTSNALD 
 Rn GFRa1 (305) SSLSVAPWCDCSNSGNDLEDCLKFLNFFKDNTCLKNAIQAFGNGSDVTMWQPAPPVQTTTATTTTAFRVKNKPLGPAGSE 
 Hs GFRa1 (305) SSLSVAPWCDCSNSGNDLEECLKFLNFFKDNTCLKNAIQAFGNGSDVTVWQPAFPVQTTTATTTTALRVKNKPLGPAGSE 
 Mm GFRa1 (305) SSLSVAPWCDCSNSGNDLEDCLKFLNFFKDNTCLKNAIQAFGNGSDVTMWQPAPPVQTTTATTTTAFRIKNKPLGPAGSE 
    *   ▼   ∆ IX  *▼        X    ●  
 Ol GFRa1 (382) TLTNVAKLED----SYGICETLQAQKLVSNQTVDMAPCLNHHLEESGTLNAISKSSP---AGLLCSQSPVLLLTLAFTFT 
Dr GFRa1a (388) PATHINHLNPADNSLYQFCGNIQAQKKKTNNTIDVL-CVDPQIDDPSSSNTISKNSSPRQMTLSGLSSQLLLLATSLHCI 
Dr GFRa1b (395) DPTLTNDLDSNADHLYSFCGSLQAQKLKSNVTLDVL-CVDQQLNDPSSFNAITRSS----TSAVCLVDWTVLLLLSLLSI 
 Rn GFRa1 (385) NEIPTHVLPP--------CANLQAQKLKSNVSGSTHLCLSDSDFGKDGLAGASSHITTKSMAAPPSCSLSSLPVLMLTAL 
 Hs GFRa1 (385) NEIPTHVLPP--------CANLQAQKLKSNVSGNTHLCISNGNYEKEGLG-ASSHITTKSMAAPPSCGLSPLLVLVVTAL 
 Mm GFRa1 (385) NEIPTHVLPP--------CANLQAQKLKSNVSGSTHLCLSDNDYGKDGLAGASSHITTKSMAAPPSCGLSSLPVMVFTAL 
  
 Ol GFRa1 (455) LTESQIKVFQLL  100% 
Dr GFRa1a (467) FTPVML------  62% 
Dr GFRa1b (470) LHLDHLTASQTV  61% 
 Rn GFRa1 (457) AALLSVSLAETS  56% 
 Hs GFRa1 (456) STLLSLTETS--  55% 





Fig. 11 Nucleotide and Amino Acid Sequences of the Gdnf Receptor. 
 
(a) The nucleotide sequence of the medaka Gfrα1 cDNA and predicted translation product are shown. The 
exons are numbered by Roman numerals while ▼ demarcate exon-intron boundaries.  Potential N-
glycolsylation sites are marked with ∆ and conserved cysteine residues are indicated with an asterisk.  The 
last cysteine residue denoted by ● does not align well with the other homologues.  The three characteristic 
functional domain of GFRα1, namely the N-terminal secretory signal peptide, GPI signal peptide and C-
terminal hydrophobic region are underlined.  However, the corresponding domains in medaka are currently 
undetermined as they do not appear to be conserved.  (b) Phylogenetic tree of Gfrα1 proteins from medaka 
and other organisms.  Bootstrap values at branching are given.  The corresponding accession number is 
indicated after the species name while in the case of medaka, the scaffold number is given instead.  Ol, 
Oryzias latipes; Dr, Danio rerio; Hs, Homo sapiens; Mm, Mus Musculus; Rn, Rattus norvegicus.   
 
 
 A BLAST search of the medaka genome database identified the isolated gfrα1 to 
Scaffold100.  In addition, the blast result also shows significant homology to Scaffold290, 
with a returned score of 82 Bits and an E-value of 5e-13, suggesting the possibility of a 
Gfrα1 paralogue in medaka although it could also well belong to any other member of the 
Gfrαs family.  However, it seems unlikely that the paralogue, if present, is expressed in 
the testis as RT-PCR using other primers failed to reveal any other distinctive sequence.   
 Medaka Gfrα1 contains 10 exons (Table 3) and like its ligand, there are no 
splicing variants.  On the other hand, human GFRα1 has two isoforms; the longer isoform 





Table 3 Structure of gfrα1 with the predicted size of exons and introns and junction sequences.  
 
 






Fig. 12 Schematic diagram of medaka gfrα1gene structure in comparison to human.   
 
Untranslated exons are showed in grey box, translated exon in filled box and introns as solid lines.  Like its 
ligand, the human GFRα1 has two isoforms; the longer isoform (Accession Number: NM_005264) has 11 
exons while exon 5 is missing in the shorter isoform (NM_145793) Diagram is drawn to scale except for 




Scaffold 100  
Exon 5’- 3’ end Exon 
Size 
(bp) 
Intron 5’-3’ end Intron 
Size 
(bp) 
1 975105-975391 AAAGCAGAGG-TCCTTCACGG 287 gtaagtgaat-ttgattgtag 239 
2 975631-975927 ATTCGGTGTT-AGCTTGCATG 297 gtaggtttga-tgccctgcag 2381 
3 978309-978392 GTAATGATTT-ATCATAGCTG 84 gtaagagttc-tttgtctcag 15425?? 
4 993818-993996 TCGAACCTGC-CTTTGACAAG 179 gtaatttttg-aaaaatcaag 230 
5 994227-994399 GTTCCAAGTA-ACATATGCAG 173 gttagactta-ttttttaaag 739 
6 995139-995248 GTCACGACTG-CGTCTTATTG 110 gtaagtttat-tcctctgcag 1475 
7 996724-996858 GGACGGTGAT-CGCTGCCTGC 135 gtaagtaaca-tttcatgtag 364 
8 997223-997407 GTAACGCCAT-AACCTTACAG 185 gtgatctgaa-gtcccctcag 2400 
9 999808-999855 GCCCAAAAGC-TCCTTGTCTG 48 gtaagtccgg-gtttttccag 2922 
10 1002778-1003817 AACCATCACC-TATACATTAA 1040   
2381 15425 2400 2922 Medaka 
Human 
   1     2          3   4   5         6                   7     8             9                 10    
57857 86074 28456 24112 
   1    2    3      4          5          6           7                     8                        9         10     11 
 32 
 
3.3 Expression Analysis 
 The gdnf- and/or gfra1-deficient mouse models are known to be neo-lethal 
(Naughton et al. 2006) and it appears that in medaka, both genes are also imperative to 
embryonic development.  Both transcripts were present in all of the six embryonic stages 
investigated (Fig 13a) and expression was detected as early as the blastodisc stage.  
Although expression level steadily declines after that, a surge was detected at stage 22 
and was maintained until hatching (Fig 13a).  Such high level and virtually ubiquitous 
expression of the genes almost certainly point to a central role played by the Gdnf/Gfrα1 
signalling pathway in the development of medaka embryos.   
 Gdnf expression also corresponds to Gfrα1 in tissues examined by RT-PCR, albeit 
in different levels (Fig. 13a).  The disparity in expression is greatest in the brain where 
the ligand could only be faintly detected even after increasing the number of PCR cycles 
to 40 (Fig 13b).  As the difference is so huge, it appears likely that another ligand 
belonging to the GFL family might be responsible for Gfrα1 signalling in the medaka 
brain.  NRTN and ARTN are likely candidates (Fig. 2) although we could not entirely 
discount the possibility of a GDNF paralogue.  Interestingly, an analysis of expression in 
zebrafish also failed to detect the presence of Gdnf in the brain (Shepherd et al. 2001).  
Hence, it seems very likely that the ligand-receptors crosstalk observed in other organism 
might also occur, at least in the case of medaka brain.  Taken together, it is probable that 
GDNF might have acquired the ability to support the survival of several neuronal 










Fig. 13 Expression analysis of gdnf and gfrα1 transcripts.  
 
a) Both Gdnf and Gfrα1 were subjected to 35 PCR cycles across all tissues and embryonic stages studied. 
Expression of both transcripts was detected during stage 2, suggesting a maternal mRNA source. 
Expression then decrease steadily until a surge was detected at Stage 22, which is approximately equal to 
day one post-fertilization. Except for the brain, ligand expression coincides with that of the receptor in all 
of the tissues investigated. b) Faint Gdnf expression was detected in the brain only after the number of PCR 
cycles was increased to 40 (denoted by a yellow *).  
b-Actin was used as calibrations (28 cycles) in the experiments. Number denotes the stage of the embryo 
while the size of the bands indicated in parentheses is determined through sequencing. Developmental 
stages of embryos are numbered according to Iwamatsu, 2004.  O, ovary; T, Testis; L, Liver; I, Intestines; 
M, Muscle; E, Eyes; B, Brain; -ve, Negative Control;  
GDNF (393bp) 
GFRα (268bp) 






 The isolated Gdnf gene is 762 bp long and encodes for a putative protein of 253 
aa.  A Blast with the medaka EST and genomic database reveals that the full length 
cDNA is comprised of four exons and separated by three introns.  In addition, sequence 
analysis also illustrates that most of the functional identified motifs of the gene are well 
conserved in medaka and transcriptional control likely to be similar to human. 
 The full length cDNA for the medaka gfrα1 obtained by RACE is 2551 bp long 
and has a putative ORF of 1401 bp for 466 aa. The predicted protein shares the best 
homology to the known vertebrate GFRα1 proteins although several domains distinctive 
to the gene do not appear to be well conserved.  Blast results revealed the gene has ten 
exons and the possibility of a paralogue in medaka.   
 Both genes are co-expressed throughout embryonic development and in most of 
the adult tissues studied.  However, there is a huge disparity in the expression level of 
Gdnf compared to its alleged receptor in the brain.  This suggests the presence of another 
binding ligand to Gfrα1 in the medaka brain and also probably, a different role for Gdnf 
in the medaka fish.   
 In conclusion, we report the successful isolation and characterization of two 
medaka genes, gdnf and gfrα1. However, further study would be needed to determine if 
the GDNF-GFRα1-RET signalling pathway, like in other vertebrates, are also conserved 
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